J. Liaño-Pons

Targeting mitochondrial metabolism for precision medicine in cancer

M. Arsenian-Henriksson, M. V. Ruiz-Pérez, Lourdes Sainero-Alcolado, 2022, Cell Death & Differentiation.

Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma

O. Bedoya-Reina, M. Mushtaq, S. Schlisio, 2022, Journal of Experimental & Clinical Cancer Research.

The Multiple Faces of MNT and Its Role as a MYC Modulator

J. León, M. Arsenian-Henriksson, J. Liaño-Pons, 2021, Cancers.

MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis

J. León, M. Berciano, M. Lafarga, 2016, Oncotarget.

The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells

I. Varela, R. Eisenman, J. León, 2020, The Journal of Biological Chemistry.

The MYC antagonist MNT autoregulates its expression and supports proliferation in MAX deficient cells

I. Varela, R. Eisenman, J. León, 2017, bioRxiv.

A novel role of MNT as a negative regulator of REL and the NF-κB pathway

A. von Kriegsheim, L. Espinosa, A. Bigas, 2020, bioRxiv.

Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development

O. Bedoya-Reina, J. Johnsen, Mohammad Alzrigat, 2023, Cancers.

A druggable conformational switch in the c-MYC transactivation domain

Dilraj Lama, K. Teilum, M. Landreh, 2024, Nature communications.